A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Status:
Recruiting
Trial end date:
2024-01-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to allow continued adavosertib treatment of patients with
advanced solid tumours participating in the adavosertib clinical pharmacology studies and to
assess the continued safety and tolerability of adavosertib for patients enrolled in
adavosertib clinical pharmacology studies (hereafter referred to as the 'parent studies') who
continue to use the therapy.